Contact this trialFirst, we need to learn more about you.
Immunotherapy
AZD0022 + Cetuximab for Solid Tumors
Recruiting1 awardPhase 1 & 2
Fairfax, Virginia
This trial is testing a new drug called AZD0022 on patients with specific tumors that have a KRASG12D mutation. The study aims to evaluate the safety, side effects, how the
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service